Clinical Trial Update: A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for TQB3454 in advanced biliary carcinoma (cholangiocarcinoma), with status ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• TQB3454

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Biliary Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING